Company Badge
USPTO Data Jan 1 1976 - Dec 30 2025
9 Patents
#11 in Zwijnaarde
#278 in Belgium
Actogenix N.v.
Forward Citations = 44
9 inventors:
Actogenix N.v.
CIPO Patents = 1
EPO Patents = 6
Forward Citations = 44
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Lothar Steidler (4 out of 28 patents)
Pieter Rottiers (4 out of 15 patents)
Veerle Snoeck (3 out of 19 patents)
4. Klaas Vandenbroucke (2 out of 12 patents)
5. Sabine Neirynck (1 out of 4 patents)
6. Erik Remaut (1 out of 3 patents)
7. Dirk Iserentant (1 out of 4 patents)
8. Wolfgang Christian Hans (1 out of 2 patents)
9. Erik René Remaut (1 out of 2 patents)
10. Sam Corveleyn (3 patents)
11. Patrick Dhaese (3 patents)
9 patents:
Actogenix N.V. is a clinical-stage biotechnology company focused on the development of novel therapeutics for the treatment of gastrointestinal disorders and cancer. The company's proprietary platform technology, Lactobacillus Biofactories, enables the oral delivery of therapeutic proteins to target specific disease areas. Actogenix is dedicated to bringing innovative and effective treatments to patients in need.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
1 patent (CIPO):
Please report any incorrect information to support@idiyas.com
6 patents (EPO):
Please report any incorrect information to support@idiyas.com